Jill de Mol receives best presentation award at the Dutch Atherosclerosis Society Symposium 2024
Month: May 2024
At the 2024 Dutch Atherosclerosis Society Symposium, held on May 23rd in Zeist, Jill de Mol from the Division of BioTherapeutics received the award for best oral presentation for her work on age-associated B cells in atherosclerosis.
During this annual symposium, organized by the Dutch Atherosclerosis Society board, basic scientists and clinicians present and discuss their recent developments in the field of atherosclerosis research. Almost the entire cardiovascular ULEI lab attended this meeting and contributed to the program. B-specific member Ilze Bot provided the keynote lecture entitled ‘Mast cells as effectors in advanced atherosclerosis’. Amanda Foks presented her research on ‘Sexual dimorphism in atherosclerotic plaques of aged Ldlr deficient mice’ and Jill de Mol presented our progress on age-associated B cells in atherosclerosis in the session of selected abstracts.

LACDR Spring Symposium 2024
Month: May 2024
On May 14 2024, Jill represented the Division of BioTherapeutics in the annual LACDR Spring Symposium and presented her research on age-associated B cells in atherosclerosis. The LACDR Spring Symposium is attended by ~150 LACDR employees. In addition, master students of BioPharmaceutical Sciences attend this Symposium to learn about our research and for whom this is a training activity.
